Back to the main directory
EarningsReview / Equity
- Pandora (Hold, TP: DKK840.00) - Strong Q2, driven by US by DnB Markets
- Grieg Seafood (Buy, TP: NOK100.00) - UK divestment in focus by DnB Markets
- Salmones Camanchaca (Buy, TP: NOK68.00) - Strong prices to offset soft Q2e by DnB Markets
- Axactor (Buy, TP: NOK13.00) - Scale benefits visible by DnB Markets
- GreenMobility - Initiation of coverage - Sharing is caring by DnB Markets
- The weekly navigator by DnB Markets
- Axactor - Buy/NOK 17: Solid yield guidance, now waiting for volumes by Nordea
- NKT - Buy/DKK 340: Strong quarter, awaiting next triggers by Nordea
- Pandora - Buy/DKK 1,100: The pandemic will fade but diamonds last forever by Nordea
- Ambu - Version 1.5 launch on track but not out of the woods by Danske Bank Equity Research
- BOOZT AB - Hold (Buy/SEK 230): It's time for a breather; we downgrade to Hold by Nordea
- Hapag-Lloyd AG (HLAG GY) by HSBC
- Hanut exploration well unsuccessful by BNP Paribas Exane
- Sunny Optical (2382 HK) by HSBC
- Deutsche Beteiligungs - Strong firepower for new acquisitions by Edison Investment Research
- Wheaton Precious Metals - Solid Q221 results set up H221 by Edison Investment Research
- SITC International (1308 HK) by HSBC
- Elektroimportøren (Buy, TP: NOK100.00) - Q2 above with positive outlook by DnB Markets
- Targovax (Buy, TP: NOK17.00) - Next step in melanoma revealed by DnB Markets
- Coloplast (Sell, TP: DKK900.00) - Slower US recovery by DnB Markets
- Lundbeck (Buy, TP: DKK275.00) - Guidance narrowed by DnB Markets
- Self Storage Group ASA (Hold, TP: NOK30.00) - Occupancy beat, but lower rents by DnB Markets
- Ambu (Buy, TP: DKK295.00) - aScope 5 delay in focus by DnB Markets
- Indonesia Banks by HSBC
- Execution and margins continue to improve by BNP Paribas Exane
- Hunter Group (Hold, TP: NOK3.00) - Minor revisions ahead of Q2 by DnB Markets
- BerGenBio (Buy, TP: NOK48.00) - Fast-track designation for 2L NSCLC key event in Q2 by DnB Markets
- Pandora (Hold, TP: DKK860.00) - Premium still warranted by DnB Markets
- Sanofi (SAN FP) by HSBC
- Freenet AG (FNTN GR) by HSBC
- Ambu - Sell/DKK 181 (Hold): Difficult setup for 2021/22 by Nordea
- Cint Group - Buy/SEK 137 (130): Strong Q2 and start of Q3 warrants target upgrade by Nordea
- New Wave Group - Buy/SEK 160 (150): Impressive margin improvement by Nordea
- Pandora - Remains a bargain, focus turns to 2022-23 growth by Danske Bank Equity Research
- Boozt - Straying from the pack but at a higher cost by Danske Bank Equity Research
- Kamux - Growth overshadows short-term margin pressure by Danske Bank Equity Research
- 三花智控（002050 CH） by HSBC
- 舜宇光学科技（2382 HK） by HSBC
- Itaú BBA on Hapvida: Soft 2Q21 Results on Weak MLR, as Expected by Itau
- Bank Norwegian - Soft Q2 figures, but better ahead by Danske Bank Equity Research
- Continued delivery amidst regulatory uncertainty by BNP Paribas Exane
- Far Eastern New Century (1402 TT) by HSBC
- Coloplast (Sell, TP: DKK900.00) - Chronic Care miss by DnB Markets
- Lundbeck (Buy, TP: DKK270.00) - by DnB Markets
- Flex LNG Minor model adjustments by DnB Markets
- Elektroimportøren (Buy, TP: NOK100.00) - Charging ahead by DnB Markets
- Selvaag Bolig (Hold, TP: NOK61.00) - Entering the Swedish market by DnB Markets
- DouYu International (DOYU US) by HSBC
- Itaú BBA on Vinci Partners: AUM Inflow Drives Positive 2Q21 Results by Itau
- Itaú BBA on Mosaico: A Very Tough Quarter, as Expected by Itau